Trexquant Investment’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-143,193
Closed -$1.21M 1677
2025
Q3
$1.21M Buy
+143,193
New +$1.39M 0.01% 1074
2019
Q3
Sell
-73,433
Closed -$584K 929
2019
Q2
$584K Buy
+73,433
New +$869K 0.05% 437
2018
Q4
Sell
-20,435
Closed -$580K 1100
2018
Q3
$580K Buy
20,435
+8,060
+65% +$192K 0.04% 500
2018
Q2
$260K Buy
+12,375
New +$234K 0.02% 719
2017
Q1
Sell
-23,661
Closed -$350K 1143
2016
Q4
$350K Buy
+23,661
New +$466K 0.06% 586

Other funds holding EVH

Trexquant Investment's EVH Position: Q4 2025 in Review

Trexquant Investment sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 143,193 shares — an estimated $1.21M sold.

Trexquant Investment first reported a position in EVH in Q4 2016 and held it in 5 quarters. The position peaked at $1.21M in Q3 2025. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Trexquant Investment reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 143,193 Evolent Health shares in Q4 2025, an estimated $1.21M.
  • Trexquant Investment first reported a position in Evolent Health in Q4 2016 and held it in 5 quarters.
  • Trexquant Investment's Evolent Health position peaked at $1.21M in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.